BioPharma Drive: Drug Pricing

DECEMBER 15, 2023

While a positive recommendation for the gene editing treatment Casgevy was expected, a clearance for Biogen’s Skyclaris, acquired through a recent acquisition, was no sure bet.

Regulations 169

Regulations Treatment Drugs 169

BioPharma Drive: Drug Pricing

JUNE 21, 2023

The regulator will issue a decision on lovo-cel by Dec. 20, roughly two weeks after a verdict is expected on a rival gene editing treatment from Vertex and CRISPR Therapeutics.

Therapies 251

Therapies Regulations Treatment 251

Drugs.com

JUNE 7, 2023

MONDAY, June 5, 2023 -- It’s tempting to treat little skin bumps on your own, but that delays proper diagnosis and treatment that may work better, federal regulators cautioned. Among the many types of skin conditions a person can contract are.

Treatment 130

Treatment FDA Regulations 130

Covalent Modifiers

MAY 9, 2024

Hopkins Journal of Medicinal Chemistry 2024 DOI: 10.1021/acs.jmedchem.4c00220 4c00220 Multiple sclerosis (MS) is a chronic disease with an underlying pathology characterized by inflammation-driven neuronal loss, axonal injury, and demyelination.

Treatment 208

Treatment Clinical Development Disease Regulations 208

Drug Target Review

MARCH 17, 2025

Neuropsychiatric treatment is on the verge of a major transformation. Neuropsychiatric disorders, affecting millions worldwide, disrupt the brain’s intricate processes of mood regulation, cognition and behaviour. “Zelquistinel is a positive modulator of NMDA receptors,” Donello explains.

Treatment 52

Treatment Licensing Licensing Science 52

Chemical Biology and Drug Design

JULY 13, 2023

Coptisine inhibits the malignancy of BC cells via regulating XPO1. This study showed that COP treatment markedly suppressed the malignant biological behaviors of bladder carcinoma cells. COP treatment modulated the expression level of cyclin D1 and CYP450 via XPO1.

Regulations 100

Regulations Bioinformatics Treatment Drugs 100

Drug Target Review

NOVEMBER 25, 2024

As the CEO of iOnctura, an innovative oncology biopharmaceutical company she co-founded in 2017, Catherine has played a key role in advancing the development of highly targeted small molecules aimed at revolutionising cancer treatment. This is exciting because often resistance builds up to these other treatments.

Treatment 52

Treatment Small Molecule Clinical Trials Trials 52

The Pharma Data

JUNE 9, 2025

A New Treatment Option for a Debilitating Joint Tumor TGCT is a rare, debilitating condition that primarily affects young and middle-aged adults, often striking individuals in their prime working years. Pimicotinib: A Promising CSF-1R Inhibitor Pimicotinib is an investigational small molecule developed by Abbisko Therapeutics Co.,

Treatment 40

Treatment Therapies Small Molecule Marketing 40

Chemical Biology and Drug Design

SEPTEMBER 30, 2023

Abstract Epigenetic regulation of genes through posttranslational regulation of proteins is a well-explored approach for disease treatment, particularly in cancer chemotherapy. Structural classification and regulatory functions of histone deacetylases and their inhibitors.

Regulations 100

Regulations Treatment FDA Disease 100

Chemical Biology and Drug Design

NOVEMBER 1, 2023

Kaempferol exerted antioxidant effects in AR-DOR by inhibiting Hsp90 to up-regulate Nrf2. In this study, 36 volunteers and 78 DOR patients (37 patients with EXD treatment) were enrolled in the clinical research. In summary, kaempferol exerts an antioxidant effect on AR-DOR by inhibiting HSP90 expression to up-regulate NRF2 expression.

Regulations 100

Regulations Treatment Clinical Research Research 100

Chemical Biology and Drug Design

JANUARY 30, 2025

Treatment with the title compound activated the TLR7-mediated NF-B pathway, triggering the IRAK4-IKK/-IB-p65 NF-B signaling cascade, which led to an increase in the expression of NF-B-regulated innate cytokines such as TNF and IL-1 in RAW264.7 macrophages.

Immune Response 100

Immune Response Regulations Treatment Research 100

Chemical Biology and Drug Design

DECEMBER 5, 2024

ABSTRACT Mer-tyrosine kinase (MERTK), a member of the AXL, TYRO3, and MERTK (TAM) family, is one of the promising targets for cancer treatment. It plays a key role in cancer cell survival and proliferation and regulates immune responses in cancer.

Immune Response 100

Immune Response Pharmacokinetics Regulations Treatment 100

SCIENMAG: Medicine & Health

NOVEMBER 27, 2023

An innovative stem cell-based treatment for Type 1 diabetes can meaningfully regulate blood glucose levels and reduce dependence on daily insulin injections, according to new clinical trial results from the University of British Columbia (UBC) and Vancouver Coastal Health (VCH).

Treatment 92

Treatment Clinical Trials Regulations Trials 92

Chemical Biology and Drug Design

JUNE 4, 2025

ABSTRACT Protein arginine methyltransferase 5 (PRMT5) is an epigenetic-related enzyme that has been shown to be a promising target for the treatment of human cancers. Finally, Western blotting was used to detect the mechanism of action of the compounds in the treatment of prostate cancer.

Treatment 100

Treatment Regulations Therapies Research 100

Drug Target Review

DECEMBER 20, 2024

These twins simulate how a patients condition might evolve without treatment, enabling researchers to compare the real-world effects of an experimental therapy against predicted outcomes. Regulators care a lot about controlling the Type 1 error rate of the clinical trial, Smith notes.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

Chemical Biology and Drug Design

JANUARY 24, 2024

A new herbal formula, YH complex, might be an effective treatment for androgenetic alopecia. From result of network analysis, the possible underlying mechanism of YH complex was closely related with the “regulation of hair cycle” and “apoptosis signaling pathway.” In depilated AGA mice, YH complex markedly promoted hair regrowth.

Regulations 100

Regulations Treatment Research 100

Chemical Biology and Drug Design

SEPTEMBER 24, 2023

This finding provides new ideas for the development of drug targets for the treatment of ischemic stroke. This research is powered to probe whether the molecular mechanism of JAS for IS treatment is coupled with microglia polarization. JAS reduces IS injury by regulating microglia polarization via PASK-EEF1A1 axis.

Regulations 100

Regulations Protein Expression Treatment Research 100

biobide

AUGUST 18, 2023

Cruelty-free cosmetics have emerged as a powerful statement within the beauty industry and Fast Moving Consumer Goods (FMCG), reflecting a growing consumer consciousness on the ethical treatment of animals. In 2004 the European Union (EU) introduced a ban on animal testing on finished products.

Regulations 92

Regulations Animal Testing Production Treatment 92

Advarra

JULY 26, 2022

Importantly, the 2018 Farm Bill preserved FDA authority to regulate products with cannabis or cannabis-derived compounds under the Federal Food, Drug, and Cosmetic (FD&C) Act and Section 351 of the Public Health Service Act. The post CBD Research: A Dive into the Regulations of Cannabis Research appeared first on Advarra.

Regulations 97

Regulations Research FDA FDA Approval 97

Chemical Biology and Drug Design

MARCH 8, 2024

Next, quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure the expression levels of Glial fibrillary acidic protein (GFAP), C3, S100 calcium binding protein A10 (S100a10), pentraxin 3 (Ptx3), toll-like receptor 4 (TLR4), and RAG in astrocytes after different treatments.

Regulations 100

Regulations Treatment Research 100

Chemical Biology and Drug Design

JANUARY 24, 2024

Baicalin alleviates OGD/R-induced SK-N-SH cell apoptosis, inflammation, and ferroptosis in vitro, and brain injury in MCAO mice in vivo, via the regulation of miR-556-3p/ACSL4 pathway. Our study showed that BCL treatment alleviated OGD/R-induced SK-N-SH cell apoptosis, inflammation and ferroptosis.

Regulations 100

Regulations RNA Treatment Research 100

Drug Target Review

APRIL 7, 2025

For example, transcriptomic processes are showing the potential to identify and track failures in gene expression and gene regulation of amyloid and tau-related biomarkers, understood as precursors to the onset of Alzheimers disease (AD). A biomarker is a measurable indicator of a biological process, disease state, or response to a treatment.

Clinical Development 69

Clinical Development Clinical Trials Clinical Pharmacology Trials 69

Chemical Biology and Drug Design

JANUARY 23, 2024

Matrine inhibits the growth and metastasis of hepatocellular carcinoma by regulating the ELAVL1/RBM3-mediated Wnt/β-catenin signaling pathway. Moreover, ELAVL1 might bind with RBM3 to positively regulate the stability of RBM3 mRNA. Nevertheless, the anti-tumor molecular mechanism of Martine in HCC is still not fully revealed.

Regulations 100

Regulations RNA Treatment Research 100

Chemical Biology and Drug Design

SEPTEMBER 6, 2023

Matrine inhibits TNBC cell proliferation, migration and invasion, promotes apoptosis, and suppresses tumor growth through down-regulation of HN1 expression. Abstract The treatment of triple-negative breast cancer (TNBC) cannot meet medical needs, and it is urgent to find new drugs for intervention.

Regulations 100

Regulations Protein Expression Treatment Drugs 100

Chemical Biology and Drug Design

MARCH 8, 2024

Circ_0139658 is directly bound to miR-653-5p to regulate YY1 expression. Brucine treatment suppressed circ_0139658 and YY1 expression but increased YY1 expression in RA-FLSs. RA-FLSs showed increased circ_0139658 and YY1 levels and decreased miR-653-5p levels.

Regulations 100

Regulations RNA Treatment Research 100

Chemical Biology and Drug Design

JANUARY 4, 2024

Furthermore, AS-IV performed a beneficial anti-cancer effect by regulating the circ_0001615/miR-873-5p/LASP1 network in the CRC. According to the IC50 of AS-IV in CRC cells, the 100 ng/mL AS-IV treatment for 24 h was chosen for the following research: Our data confirmed that AS-IV is a beneficial anti-cancer agent in CRC cells.

Regulations 100

Regulations RNA Treatment Research 100

Chemical Biology and Drug Design

OCTOBER 4, 2023

After a series of data analyses and experimental verification, we found formononetin may inhibit hepatocyte metabolism and cell cycle regulation-related pathways by modulating ESR1 , CCNA2 , and CHEK1 , thereby inhibiting HepG2 cell proliferation. This study provides insights into potential HCC treatments.

Treatment 20

Treatment Regulations Disease Drugs 20

DrugBank

JULY 8, 2024

Revolutionizing Treatment Through the Skin with Transdermal Drug Delivery Systems The human skin, often perceived as a passive barrier to the external environment, holds potential as a route for drug administration. This membrane regulates the diffusion of the drug from the reservoir into the skin.

Treatment 98

Treatment Drugs Clinical Trials Engineering 98

ASPET

SEPTEMBER 16, 2024

GBM has a poor prognosis despite aggressive treatment, in part due to lack of adequate drug permeability at the BBB. Various DDR inhibitors, targeting the key regulators of these pathways such as ataxia telangiectasia mutated and Rad3-related (ATR), are being explored as radio- and chemo-sensitizers.

Pharmacogenetics 100

Pharmacogenetics Treatment DNA Pharmacokinetics 100

Drugs.com

OCTOBER 11, 2024

11, 2024 -- Hucksters offering bogus stem cell treatments can be deterred through government action, a new study says.About 60% of direct-to-consumer advertising from fly-by-night stem cell clinics ceased after regulators in Canada and. FRIDAY, Oct.

Government 130

Government Regulations Treatment 130

Covalent Modifiers

MAY 15, 2023

Chan, Gui Lu European Journal of Medicinal Chemistry , 2023 [link] Aurora kinases, which belong to the serine/threonine protein family, play critical roles in the regulation of the cell cycle and mitotic spindle assembly. Despite the development of some reversible Aurora kinase inhibitors, none has been approved for clinical use yet.

Treatment 100

Treatment Regulations Therapies Drugs 100

Chemical Biology and Drug Design

JULY 4, 2023

Acacetin may be a promising drug in complementary therapy of cancer treatment. Acacetin treatment induced bax's expression and repressed bcl-2's expression. Abstract Acacetin is a natural flavonoid compound found in diverse plants, which has strong anti-inflammatory and anti-cancer activities.

Bioinformatics 100

Bioinformatics Regulations Treatment Therapies 100

BioPharma Drive: Drug Pricing

AUGUST 17, 2023

The mixed results supporting the treatment, Sohonos, have proven a tough case for regulators and led to different outcomes in the U.S. and Europe.

FDA 130

FDA Regulations Treatment Drugs 130

ASPET

AUGUST 5, 2024

Long term treatment leads to increases in receptor abundance and activity with no changes in mRNA supporting a role as pharmacological chaperones. Overexpression of RTP4 causes an increase and knock-down causes a decrease in the levels of CB 1 R, DOR, and CB 1 R-DOR interacting complexes; this is accompanied by parallel changes in signaling.

Small Molecule 100

Small Molecule Regulations Treatment 100

Chemical Biology and Drug Design

DECEMBER 18, 2023

The Buzhong Yiqi decoction regulated the PI3K-AKT signaling pathway in non-small cell lung cancer A549 cells. The Buzhong Yiqi decoction (BZYQD), traditional Chinese medicine (TCM) formula, has been reported to exhibit clinical efficacy in the treatment of NSCLC. Nevertheless, the underlying molecular mechanism remains elusive.

Treatment 100

Treatment Clinical Trials Regulations Trials 100

Covalent Modifiers

DECEMBER 22, 2023

2023.11.008 The TRF2 shelterin component is an essential regulator of telomere homeostasis and genomic stability. We demonstrate that APOD53 impairs cancer cell growth and find that co-treatment with APOD53 can exacerbate telomere replication stress caused by the G4 stabilizer RHPS4 and low dose aphidicolin (APH).

DNA 162

DNA Regulations Treatment 162

Chemical Biology and Drug Design

JULY 16, 2023

NAFLD mice model was established by HFD for 12 weeks, and LQ treatment for 1 week. HFD mice showed significant increases in hepatic TG and TC, and plasm TC, TG, and LDL-C in blood lipids, while HDL-C significantly decreased, and LQ treatment reversed their levels ( p  < 0.05).

Regulations 100

Regulations Treatment Disease Research 100